173 related articles for article (PubMed ID: 12499915)
1. The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2.
Eibl G; Reber HA; Wente MN; Hines OJ
Pancreas; 2003 Jan; 26(1):33-41. PubMed ID: 12499915
[TBL] [Abstract][Full Text] [Related]
2. [NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway].
Huang DS; Xu X; Zheng SS; Cheng JF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):601-5. PubMed ID: 16274041
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
4. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
[TBL] [Abstract][Full Text] [Related]
6. Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.
Tian G; Yu JP; Luo HS; Yu BP; Yue H; Li JY; Mei Q
World J Gastroenterol; 2002 Jun; 8(3):483-7. PubMed ID: 12046075
[TBL] [Abstract][Full Text] [Related]
7. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines.
Buecher B; Broquet A; Bouancheau D; Heymann MF; Jany A; Denis MG; Bonnet C; Galmiche JP; Blottière HM
Dig Liver Dis; 2003 Aug; 35(8):557-65. PubMed ID: 14567460
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
11. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells.
Eibl G; Bruemmer D; Okada Y; Duffy JP; Law RE; Reber HA; Hines OJ
Biochem Biophys Res Commun; 2003 Jul; 306(4):887-97. PubMed ID: 12821125
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
Kusunoki N; Yamazaki R; Kawai S
Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
Levitt RJ; Pollak M
Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282
[TBL] [Abstract][Full Text] [Related]
14. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
Cheng J; Imanishi H; Amuro Y; Hada T
Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
[TBL] [Abstract][Full Text] [Related]
15. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
16. Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.
Shaik MS; Chatterjee A; Singh M
Clin Cancer Res; 2004 Feb; 10(4):1521-9. PubMed ID: 14977856
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
Li M; Wu X; Xu XC
Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
[TBL] [Abstract][Full Text] [Related]
19. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ
Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
